Myelodysplastic/myeloproliferative diseases Clinical Trials

Delta Trials indexes 61 clinical trials for Myelodysplastic/myeloproliferative diseases in its publicly accessible dataset. Of these, 2 enrolling participants at this time and 51 trials have reached completion. This research takes place spanning 98 research sites around the world. An additional 8 trials are in preparatory or other active non-recruiting stages. Since 2020, 8 trials were terminated, illustrating the dynamic nature of clinical research. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.